首页> 外文期刊>European journal of ophthalmology >Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?
【24h】

Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?

机译:剥脱性青光眼有心血管疾病病史的目标眼压是否有差异?

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To investigate if patients with exfoliation glaucoma (XFG) with cardiovascular disease (CVD) require different target intraocular pressure (IOP) compared to patients with XFG with no CVD for long-term stability. METHODS: A retrospective, multicenter, observational cohort analysis included consecutive patients with XFG from 9 European academic centers, with a minimum of 5 years follow-up. RESULTS: In 201 patients, there was a statistical difference between progressed and non-progressed patients in mean (p=0.0049) and peak (p=0.015) IOP, variance of IOP (p=0.028), and number of medicine changes/year (p=0.0037). At a mean IOP >/=22 mmHg, patients progressed in 84% (32/38), between 14 and 21 mmHg in 54% (81/151), and at /=20 mmHg, 8% (1/12) of patients with severe CVD remained stable in contrast to 38% (16/42) of patients with mild and 21% (4/19) with no CVD history (p=0.0093). By multivariant regression analysis of the IOP and CVD measures, mean IOP was a risk factor for progression (p=0.0097). CONCLUSIONS: Although IOP is the main determinant of progression in XFG under treatment, history of severe CVD should be further investigated as potential risk factor for glaucomatous progression.
机译:目的:研究与没有CVD的XFG患者相比,患有心血管疾病(CVD)的剥脱性青光眼(XFG)患者是否需要不同的目标眼内压(IOP),以实现长期稳定性。方法:一项回顾性,多中心,观察性队列分析包括来自9个欧洲学术中心的连续XFG患者,至少随访5年。结果:在201名患者中,进展和未进展患者的平均眼压(p = 0.0049)和峰值(p = 0.015),眼压的方差(p = 0.028)和每年换药次数之间存在统计学差异(p = 0.0037)。在平均眼压> / = 22 mmHg时,患者进展为84%(32/38),在14到21 mmHg之间为54%(81/151),在≤13mmHg时为33%(4/12) 。根据CVD病史,两组之间的进展速度没有差异(p = 0.65)。但是,对于轻度或无CVD患者,允许 / = 20 mmHg时,严重CVD的患者中有8%(1/12)保持稳定,而轻度CVD的患者中有38%(16/42)和无CVD的患者中有21%(4/19) (p = 0.0093)。通过对IOP和CVD进行多变量回归分析,平均IOP是进展的危险因素(p = 0.0097)。结论:尽管眼压是接受治疗的XFG进展的主要决定因素,但应进一步研究严重CVD的病史作为青光眼进展的潜在危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号